|
Index of reports
> Cases with Lung Infection ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) where reactions include lung infection. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Herceptin side effects in 52 year old female
Reported by a physician from United States on 2012-05-02
Patient: 52 year old female
Reactions: White Blood Cell Count Decreased, Lung Infection, Myocardial Infarction, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: over 60 min
Paclitaxel
Dosage: over 60 min weekly
Indication: Breast Cancer
Start date: 2009-12-02
Herceptin
Dosage: over 30 min weekly x 12 weeks.
Epirubicin Hydrochloride
Dosage: over 15 min on day 1
Indication: Breast Cancer
Start date: 2009-12-02
Herceptin
Dosage: over 90 min week 1, then 2mg/kg iv over 30 min during subsequent 12 weeks
Indication: Breast Cancer
Start date: 2009-12-02
Fluorouracil
Dosage: on day 1
Indication: Breast Cancer
Start date: 2009-12-02
Cyclophosphamide
Dosage: over 30 min on day 1
Indication: Breast Cancer
Start date: 2009-12-02
Possible Herceptin side effects in female
Reported by a physician from United States on 2012-02-21
Patient: female, weighing 149.0 kg (327.8 pounds)
Reactions: Skin Ulcer, Lung Infection, Skin Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: over 90 min on day 1, last administered date : 9 sept 2011
Indication: Breast Cancer
Start date: 2008-11-06
Avastin
Dosage: over 30-60 min on day 1, last administered date :19/aug/2011
Indication: Breast Cancer
Start date: 2008-11-06
Possible Herceptin side effects in female
Reported by a physician from United States on 2011-11-22
Patient: female
Reactions: Lung Infection, White Blood Cell Count Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Herceptin
Start date: 2005-08-11
Ixabepilone
Indication: Breast Cancer Metastatic
Herceptin
Indication: Breast Cancer Metastatic
Start date: 2005-08-11
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from United States on 2011-11-22
Patient: female
Reactions: White Blood Cell Count Decreased, Lung Infection, Anaemia, Hypotension, Platelet Count Decreased, Hypoalbuminaemia, Myocardial Infarction, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: given over 90 min for week 1
Indication: Breast Cancer
Start date: 2009-02-12
Herceptin
Dosage: given over 30 min from week 2
Start date: 2009-02-01
Fluorouracil
Dosage: on day 1 route ivp
Indication: Breast Cancer
Start date: 2010-10-02
Epirubicin Hydrochloride
Dosage: over 15 min on day 1
Indication: Breast Cancer
Start date: 2010-10-02
Paclitaxel
Dosage: over 60 min weekly
Indication: Breast Cancer
Start date: 2009-02-12
Herceptin
Herceptin
Start date: 2010-10-02
Cyclophosphamide
Dosage: over 30 min on day 1
Indication: Breast Cancer
Start date: 2010-10-02
Possible Herceptin side effects in 52 year old female
Reported by a physician from United States on 2011-11-21
Patient: 52 year old female
Reactions: White Blood Cell Count Decreased, Pneumonia, Hypotension, Lung Infection, Anaemia, Coronary Artery Disease, Neuropathy Peripheral, Platelet Count Decreased, Hypoalbuminaemia, Neutrophil Count Decreased, Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: over 90 min week 1, then 2mg/kg iv over 30 min during subsequent 12 weeks
Indication: Breast Cancer
Start date: 2009-12-02
Fluorouracil
Dosage: on day 1
Indication: Breast Cancer
Start date: 2009-12-02
Herceptin
Dosage: over 30 min weekly x 12 weeks.
Paclitaxel
Dosage: over 60 min weekly
Indication: Breast Cancer
Start date: 2009-12-02
Cyclophosphamide
Dosage: over 30 min on day 1
Indication: Breast Cancer
Start date: 2009-12-02
Herceptin
Dosage: over 60 min
Epirubicin Hydrochloride
Dosage: over 15 min on day 1
Indication: Breast Cancer
Start date: 2009-12-02
Possible Herceptin side effects in female
Reported by a physician from United States on 2011-10-25
Patient: female
Reactions: White Blood Cell Count Decreased, Hyperalbuminaemia, Hypotension, Lung Infection, Anaemia, Platelet Count Decreased, Myocardial Infarction, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: over 90 min for 1 week
Indication: Breast Cancer
Start date: 2009-02-12
Herceptin
Dosage: over 30 min for 12weeks
Herceptin
Dosage: 3 weeks
Herceptin
Dosage: over 60 min continued till 52 weeks from first prescription.
Cyclophosphamide
Dosage: over 30 min on day 1
Indication: Breast Cancer
Start date: 2010-10-02
Fluorouracil
Dosage: on day 1 route ivp
Indication: Breast Cancer
Start date: 2010-10-02
Epirubicin Hydrochloride
Dosage: over 15 min on day 1
Indication: Breast Cancer
Start date: 2010-10-02
Herceptin
Dosage: over 30 min during susequent 12 weeks
Herceptin
Dosage: for 21 cycle
Paclitaxel
Dosage: over 60 min weekly
Indication: Breast Cancer
Start date: 2009-02-12
|
